Inhaled Fluticasone Propionate Reduces Concentration ofMycoplasma pneumoniae,Inflammation, and Bronchial Hyperresponsiveness in Lungs of Mice | Zendy

Hong Wei Chu | Zendy; J. Campbell | Zendy; John G. Rino | Zendy; Ronald J. Harbeck | Zendy; Richard J. Martin | Zendy

Open Access

Inhaled Fluticasone Propionate Reduces Concentration ofMycoplasma pneumoniae,Inflammation, and Bronchial Hyperresponsiveness in Lungs of Mice

Author(s) -

Hong Wei Chu,

J. Campbell,

John G. Rino,

Ronald J. Harbeck,

Richard J. Martin

Publication year - 2004

Publication title -

the journal of infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.69

H-Index - 252

eISSN - 1537-6613

pISSN - 0022-1899

DOI - 10.1086/382050

Subject(s) - fluticasone propionate , mycoplasma pneumoniae , bronchial hyperresponsiveness , inflammation , medicine , asthma , immunology , fluticasone , inhalation , mycoplasmataceae , mycoplasma , respiratory disease , pneumonia , lung , microbiology and biotechnology , mollicutes , anesthesia , biology

Mycoplasma pneumoniae has been shown to induce airway inflammation and bronchial hyperresponsiveness (BHR) in mice. Inhaled corticosteroids are the mainstay of asthma treatment, but their effects on M. pneumoniae and associated airway inflammation and BHR are poorly understood.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research